LMR Partners’s Intersect ENT, Inc XENT Stock Holding History

LMR Partners’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-173,473	Closed	-$4.86M	–	1568
2022 Q1	$4.86M	Buy	173,473 +93,679	+117%	+$2.57M	0.06%	332
2021 Q4	$2.18M	Hold	79,794	–	–	0.02%	445
2021 Q3	$2.17M	Buy	+79,794	New	+$1.97M	0.02%	432

LMR Partners's XENT Position: Q2 2022 in Review

LMR Partners sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 173,473 shares — an estimated $4.86M sold.

LMR Partners first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $4.86M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

LMR Partners reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
LMR Partners sold 173,473 Intersect ENT, Inc shares in Q2 2022, an estimated $4.86M.
LMR Partners first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
LMR Partners's Intersect ENT, Inc position peaked at $4.86M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.